Mar 29, 2021 / 04:00PM GMT
Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst
Great. Welcome back, everyone, as we continue the 2021 JPMorgan Virtual Napa Valley Biotech Forum. We're continuing the day sessions with Jazz, and I'm joined by a number of members of the management team, including the company's Chairman and CEO, Bruce Cozadd; Head of R&D and Chief Medical Officer, Robert Iannone; Chief Operating Officer, Dan Swisher; as well as Andrea Flynn, who heads up IR. (Operator Instructions)
You can use that as the session is going to send any questions through the portal, I can ask them to management. There's a little lag on that. So feel free to just send them as you think of them while we're going, and then I'll ask management.
So before we get into Q&A, Bruce, maybe you can just start with a couple of opening comments to kind of frame the conversation, and we can take it from there.
Bruce C. Cozadd - Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO
Yes. So Jess, great to be with you. And Dan, Rob and I are really excited
Jazz Pharmaceuticals PLC at JPMorgan NAPA Valley Forum (Virtual) Transcript
Mar 29, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers